Neuroone Medical Technologies (NMTC) Non-Current Assets (2011 - 2026)
Neuroone Medical Technologies (NMTC) posted Non-Current Assets of $461160.0 for Q1 2026, down 9.67% on a QoQ basis from $510525.0 in Q4 2025, and down 34.36% year-over-year from $702609.0 in Q1 2025.
Neuroone Medical Technologies (NMTC) Non-Current Assets (2011 - 2026) Analysis & Trends
Neuroone Medical Technologies' Non-Current Assets history runs 12 years deep, the most recent figure standing at $461160.0 for Q1 2026.
- Quarterly Non-Current Assets fell 34.36% year-over-year to $461160.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 28.57% YoY) and the FY2025 annual result came in at $559363.0, down 24.31% from the prior year.
- Non-Current Assets was $461160.0 for Q1 2026 at Neuroone Medical Technologies, down from $510525.0 in the prior quarter.
- Across five years, Non-Current Assets topped out at $879353.0 in Q2 2023 and bottomed at $461160.0 in Q1 2026.
- A 5-year average of $693284.4 and a median of $693233.0 in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets surged 37.04% — and 2025, when it slumped 34.77%.
- Neuroone Medical Technologies' Non-Current Assets stood at $693233.0 in 2022, then advanced by 5.21% to $729371.0 in 2023, then increased by 7.31% to $782665.0 in 2024, then slumped by 34.77% to $510525.0 in 2025, then retreated by 9.67% to $461160.0 in 2026.
- Business Quant data shows NMTC's Non-Current Assets at $461160.0 in Q1 2026, $510525.0 in Q4 2025, and $559363.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 84.92 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 32.95 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 35.67 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.09 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.30 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 20.47 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 26.70 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 6.35 Bn |
| 10 | Neuroone Medical Technologies | 7.99 Mn | 5.19 Mn | 990,264.00 | 461,160.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 461,160.00 |
| Dec 31, 2025 | 510,525.00 |
| Sep 30, 2025 | 559,363.00 |
| Jun 30, 2025 | 648,734.00 |
| Mar 31, 2025 | 702,609.00 |
| Dec 31, 2024 | 782,665.00 |
| Sep 30, 2024 | 739,015.00 |
| Jun 30, 2024 | 827,160.00 |
| Mar 31, 2024 | 685,158.00 |
| Dec 31, 2023 | 729,371.00 |
| Sep 30, 2023 | 784,389.00 |
| Jun 30, 2023 | 879,353.00 |
| Mar 31, 2023 | 848,549.00 |
| Dec 31, 2022 | 693,233.00 |
| Sep 30, 2022 | 646,846.00 |
| Jun 30, 2022 | 641,659.00 |
| Mar 31, 2022 | 646,046.00 |
| Dec 31, 2021 | 607,928.00 |
| Sep 30, 2021 | 646,484.00 |
| Jun 30, 2021 | 537,295.00 |